News tagged with antiplatelet therapy
Related topics: clopidogrel , patients , coronary intervention , thrombosis , myocardial infarction
Antiplatelet drugs don't up ICH risk in new study
(HealthDay)—Pre-existing antiplatelet use does not seem to be associated with an increased risk of ischemic hemorrhage (ICH), according to an observational study published in the February issue of Academic Em ...
Cardiology
Mar 25, 2013 |
not rated yet |
0
Prehospital antiplatelets improve graft intervention outcomes
(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous ...
Cardiology
Jan 28, 2013 |
not rated yet |
0
Aspirin resistance ups severity in acute ischemic stroke
(HealthDay)—In patients with acute ischemic stroke, aspirin resistance is associated with increased stroke severity and infarct size, according to research published online Nov. 19 in the Archives of Ne ...
Cardiology
Nov 21, 2012 |
not rated yet |
0
Study finds drug-eluting stents exhibit some benefits over bare-metal stents in patients over 80, though both demonstrat
Rarely tested in patients over the age of 80, a study found that drug-eluting stents exhibited some benefits over bare-metal stents, though both types of stents demonstrated a clinical benefit. Results of the XIMA trial were ...
Cardiology
Oct 26, 2012 |
not rated yet |
0
Duration of antiplatelet drugs for drug-eluting stents studied
(HealthDay)—In patients receiving drug-eluting stents, dual antiplatelet therapy can be safely discontinued during the first year, according to two studies published online Sept. 19 in the Journal of th ...
Cardiology
Sep 20, 2012 |
not rated yet |
0
Aspirin-clopidogrel no better than aspirin alone for patients with lacunar stroke
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of gastrointestinal bleeding, ...
Cardiology
Aug 29, 2012 |
not rated yet |
0
|
Global platelet reactivity and high risk ACS patients
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Omission of aspirin from antiplatelet regimen: The WOEST study
Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...
Cardiology
Aug 28, 2012 |
not rated yet |
0
Personalized antiplatelet treatment improves outcome after PCI
Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Low and comparable rates of stent thrombosis found with zotarolimus- and sirolimus-eluting stents
Rates of stent thrombosis at three years were low and comparable between zotarolimus-eluting and sirolimus-eluting stents, according to findings from the PROTECT study described here today at ESC Congress 2012.
Cardiology
Aug 27, 2012 |
not rated yet |
0
Novel anti-platelet therapy reduces risk of cardiac events in patients with history of heart attack
According to new research from Brigham and Women's Hospital (BWH), adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the long-term risk of recurrent cardiovascular ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
Aspirin still first-line therapy for unstable angina/NSTEMI
(HealthDay) -- Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor can be used in place of clopidogrel or prasugrel ...
Cardiology
Jul 17, 2012 |
not rated yet |
0
Use of drug-eluting stents varies widely; Modestly correlated with coronary artery restenosis risk
A study based on more than 1.5 million percutaneous coronary intervention procedures (such as balloon angioplasty or stent placement to open narrowed coronary arteries) suggests that the use of drug-eluting stents varies ...
Cardiology
Jul 09, 2012 |
not rated yet |
0
New class of platelet blockers proves effective in phase III trial
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
New 'real-world' reassuring data from the SCAAR registry
A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has found that PCI implantations using a new generation of ...
Cardiology
Jan 09, 2012 |
not rated yet |
0
